Theramyt Novobiologics Profile
Key Indicators
- Authorised Capital ₹ 6.64 M
as on 22-04-2024
- Paid Up Capital ₹ 4.94 M
as on 22-04-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 329.14%
(FY 2016)
- Profit 87.37%
(FY 2016)
- Ebitda 87.68%
(FY 2016)
- Net Worth -0.91%
(FY 2016)
- Total Assets -0.95%
(FY 2016)
About Theramyt Novobiologics
- CIN/LLPIN
U73100KA2013PTC070233
- Company No.
070233
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2013
- Date of AGM
28 Jun 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Theramyt Novobiologics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirban Bhattacharya  | Director | 01-Oct-2016 | Current |
| Kavitha Rodrigues | Director | 22-Jul-2013 | Current |
Financial Performance and Corporate Structure Insights of Theramyt Novobiologics.
Theramyt Novobiologics Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 329.14% increase. The company also saw a substantial improvement in profitability, with a 87.37% increase in profit. The company's net worth dipped by a decrease of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Theramyt Novobiologics?
In 2017, Theramyt Novobiologics had a promoter holding of 97.76% and a public holding of 2.24%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theramyt Novobiologics?
Theramyt Novobiologics has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theramyt Novobiologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theramyt Novobiologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
